Search
Descriptor English: Pharmacoepidemiology
Descriptor Spanish: Farmacoepidemiología
Descriptor Portuguese: Farmacoepidemiologia
Descriptor French: Pharmacoépidémiologie
Entry term(s): Epidemiologies, Pharmaceutical
Epidemiology, Pharmaceutical
Pharmaceutical Epidemiologies
Pharmaceutical Epidemiology
Tree number(s): H01.158.703.045
H02.403.720.500.650
H02.628.413
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D017891
Scope note: The science concerned with the benefit and risk of drugs used in populations and the analysis of the outcomes of drug therapies. Pharmacoepidemiologic data come from both clinical trials and epidemiological studies with emphasis on methods for the detection and evaluation of drug-related adverse effects, assessment of risk vs benefit ratios in drug therapy, patterns of drug utilization, the cost-effectiveness of specific drugs, methodology of postmarketing surveillance, and the relation between pharmacoepidemiology and the formulation and interpretation of regulatory guidelines. (Pharmacoepidemiol Drug Saf 1992;1(1); J Pharmacoepidemiol 1990;1(1))
Allowable Qualifiers: CL classification
EC economics
ED education
ES ethics
HI history
IS instrumentation
LJ legislation & jurisprudence
MT methods
OG organization & administration
SN statistics & numerical data
ST standards
TD trends
Previous Indexing: Epidemiologic Methods (1985-1993)
Epidemiology (1984-1993)
Pharmacology (1984-1993)
Public MeSH Note: 94
History Note: 94
Entry Version: PHARMACOEPIDEMIOL
DeCS ID: 31194
Unique ID: D017891
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 1994/01/01
Date of Entry: 1993/02/16
Revision Date: 2009/07/06
Pharmacoepidemiology - Preferred
Concept UI M0027034
Scope note The science concerned with the benefit and risk of drugs used in populations and the analysis of the outcomes of drug therapies. Pharmacoepidemiologic data come from both clinical trials and epidemiological studies with emphasis on methods for the detection and evaluation of drug-related adverse effects, assessment of risk vs benefit ratios in drug therapy, patterns of drug utilization, the cost-effectiveness of specific drugs, methodology of postmarketing surveillance, and the relation between pharmacoepidemiology and the formulation and interpretation of regulatory guidelines. (Pharmacoepidemiol Drug Saf 1992;1(1); J Pharmacoepidemiol 1990;1(1))
Preferred term Pharmacoepidemiology
Entry term(s) Epidemiologies, Pharmaceutical
Epidemiology, Pharmaceutical
Pharmaceutical Epidemiologies
Pharmaceutical Epidemiology



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.


Go to survey